Nicolett Weston, APRN
Nurse Practitioner · Hamilton, MTNPI 1003076639
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 134 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 134 payments — averaging $19.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$547
- AbbVie$274
- Otsuka America Pharmaceutical, Inc.$243
- Pfizer$243
- Novo Nordisk$168
- Lilly USA, LLC$145
- plus $972 from 20 others
What the payments were for
- Food & beverage$2,593100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 29 | $547 |
| AbbVie | 12 | $274 |
| Otsuka America Pharmaceutical, Inc. | 10 | $243 |
| Pfizer | 14 | $243 |
| Novo Nordisk | 10 | $168 |
| Lilly USA, LLC | 9 | $145 |
| Amgen | 6 | $121 |
| Astellas Pharma US Inc | 4 | $114 |
| Sanofi Pasteur Inc. | 6 | $110 |
| GSK | 7 | $107 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $100 |
| Boehringer Ingelheim | 4 | $58 |
| Exact Sciences | 2 | $46 |
| Organogenesis Inc. | 1 | $40 |
| Supernus Pharmaceuticals, Inc. | 2 | $40 |
| Merck | 2 | $37 |
| Galderma Laboratories, L.p. | 1 | $35 |
| Eisai Inc. | 2 | $29 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Mylan Specialty L.p. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Krystal Biotech Inc | 1 | $15 |
| Novartis | 1 | $13 |
| Bioventus LLC | 1 | $12 |
How this compares
$2,593 in reported general payments places this provider in the 95th percentile of 357 nurse practitioner providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 57 | $39,534 |
| EliquisApixaban | 44 | $35,611 |
| OzempicSemaglutide | 26 | $33,748 |
| XareltoRivaroxaban | 43 | $22,241 |
| MounjaroTirzepatide | 11 | $14,981 |
| TrulicityDulaglutide | 13 | $12,751 |
| Spiriva HandihalerTiotropium Bromide | 17 | $9,324 |
| MyrbetriqMirabegron | 15 | $8,420 |
| LinzessLinaclotide | 11 | $8,353 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $5,129 |
| SymbicortBudesonide/Formoterol Fumarate | 17 | $4,420 |
| Esomeprazole Magnesium | 35 | $3,727 |
| NexiumEsomeprazole Magnesium | 13 | $3,220 |
| Levothyroxine Sodium | 285 | $2,446 |
| Lisdexamfetamine Dimesylate | 11 | $1,909 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $107 | $39,53457 claims |
| PfizerEliquis | $243 | $35,61144 claims |
| Novo NordiskOzempic | $168 | $33,74826 claims |
| Lilly USA, LLCMounjaro, Trulicity | $145 | $27,73224 claims |
| Astellas Pharma US IncMyrbetriq | $114 | $8,42015 claims |
| AbbVieLinzess | $274 | $8,35311 claims |
| AstraZenecaSymbicort, Nexium | $547 | $7,64030 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 357 nurse practitioner providers in Montana.
Other nurse practitioner in Hamilton
- Sarah BergMissoula$381K
- Arlon BennettFlorence$268K
- Sydney HansonButte$11K
- Jennifer TerrellBillings$7K
- Amanda Abrams-BuerkleyBillings$6K
- Bowen TrystiansonGreat Falls$6K
- Andrea LappBillings$4K
- Amber MolnarGreat Falls$4K
- Jessica BosoGreat Falls$4K
- Whitney McKinleyGreat Falls$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.